American Vietnamese Biotech Incorporation (HNX:AMV)
1,200.00
-100.00 (-7.69%)
At close: Aug 12, 2026
HNX:AMV Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5,096 | 4,985 | 16,194 | 38,839 | 77,996 | 29,030 |
Short-Term Investments | 3,711 | 1,749 | 1,080 | 45,347 | - | - |
Trading Asset Securities | - | 55,638 | - | - | - | - |
Cash & Short-Term Investments | 8,807 | 62,371 | 17,274 | 84,185 | 77,996 | 29,030 |
Cash Growth | -39.41% | 261.07% | -79.48% | 7.94% | 168.67% | 9.88% |
Accounts Receivable | 138,186 | 132,460 | 295,328 | 161,836 | 234,162 | 105,822 |
Other Receivables | 401,287 | 277,063 | 3,814 | 4,792 | 2,972 | 24,115 |
Receivables | 539,472 | 488,832 | 361,992 | 166,628 | 237,134 | 129,936 |
Inventory | 72,370 | 51,867 | 49,084 | 312,592 | 238,306 | 308,283 |
Prepaid Expenses | 81.59 | 235.64 | 182.38 | 197.82 | 389.73 | 182.63 |
Other Current Assets | 205,053 | 58,413 | 523,360 | 1,018,495 | 926,535 | 538,524 |
Total Current Assets | 825,784 | 661,718 | 951,893 | 1,582,098 | 1,480,361 | 1,005,956 |
Property, Plant & Equipment | 171,805 | 189,903 | 194,440 | 242,962 | 375,803 | 383,685 |
Long-Term Investments | 701,999 | 730,720 | 621,834 | - | - | - |
Goodwill | 109.17 | 119.09 | 439.88 | 317.57 | 452.08 | - |
Other Intangible Assets | 109,674 | 109,347 | 122,522 | 41,365 | 37,798 | 34,305 |
Other Long-Term Assets | 3,432 | 191,394 | 64,512 | 106,176 | 105,628 | 106,093 |
Total Assets | 1,938,723 | 1,883,202 | 1,955,641 | 1,972,918 | 2,000,041 | 1,530,039 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 62,650 | 20,725 | 15,246 | 14,533 | 58,322 | 38,304 |
Accrued Expenses | 37,240 | 33,361 | 32,802 | 24,706 | 14,354 | 10,081 |
Short-Term Debt | 160,626 | 149,626 | 28,125 | 40,279 | - | - |
Current Portion of Long-Term Debt | - | - | - | - | 30,271 | 31,712 |
Current Income Taxes Payable | 1,529 | 2,289 | 1,575 | 99.34 | 1,825 | 237.82 |
Current Unearned Revenue | 2,328 | 2,973 | - | - | - | - |
Other Current Liabilities | 115,630 | 77,530 | 78,345 | 79,731 | 77,368 | 76,857 |
Total Current Liabilities | 380,002 | 286,504 | 156,093 | 159,347 | 182,139 | 157,192 |
Long-Term Debt | - | - | 126,500 | 126,484 | 140,248 | 150,772 |
Other Long-Term Liabilities | - | - | 337.8 | 1,358 | 2,116 | 7,844 |
Total Liabilities | 380,002 | 286,504 | 282,931 | 287,189 | 324,504 | 315,807 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,311,057 | 1,311,057 | 1,311,057 | 1,311,057 | 1,311,057 | 911,089 |
Retained Earnings | 181,613 | 219,192 | 291,829 | 302,854 | 292,696 | 238,764 |
Comprehensive Income & Other | -395.3 | -395.3 | -395.3 | -395.3 | -395.3 | -175 |
Total Common Equity | 1,492,274 | 1,529,853 | 1,602,490 | 1,613,515 | 1,603,357 | 1,149,678 |
Minority Interest | 66,446 | 66,846 | 70,219 | 72,214 | 72,181 | 64,554 |
Shareholders' Equity | 1,558,721 | 1,596,699 | 1,672,710 | 1,685,729 | 1,675,538 | 1,214,232 |
Total Liabilities & Equity | 1,938,723 | 1,883,202 | 1,955,641 | 1,972,918 | 2,000,041 | 1,530,039 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 160,626 | 149,626 | 154,625 | 166,763 | 170,519 | 182,483 |
Net Cash (Debt) | -151,819 | -87,255 | -137,351 | -82,577 | -92,523 | -153,453 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1158.45 | -665.53 | -1047.64 | -629.85 | -861.21 | -1823.01 |
Filing Date Shares Outstanding | 131.11 | 131.11 | 131.11 | 131.11 | 131.11 | 86.77 |
Total Common Shares Outstanding | 131.11 | 131.11 | 131.11 | 131.11 | 131.11 | 86.77 |
Working Capital | 445,782 | 375,215 | 795,800 | 1,422,751 | 1,298,222 | 848,765 |
Book Value Per Share | 11382.23 | 11668.86 | 12222.89 | 12306.98 | 12229.50 | 13249.07 |
Tangible Book Value | 1,382,491 | 1,420,387 | 1,479,529 | 1,571,833 | 1,565,107 | 1,115,373 |
Tangible Book Value Per Share | 10544.86 | 10833.91 | 11285.01 | 11989.05 | 11937.75 | 12853.74 |
Buildings | 10,895 | 10,895 | 10,895 | 10,895 | - | - |
Machinery | 228,156 | 227,855 | 209,311 | 169,372 | - | - |
Construction In Progress | 19,902 | 26,445 | 27,467 | 109,660 | 238,904 | 261,735 |